Cargando…
Stroma-targeting strategies in pancreatic cancer: Past lessons, challenges and prospects
Pancreatic ductal adenocarcinoma (PDAC) is projected to emerge as the second leading cause of cancer-related death after 2030. Extreme treatment resistance is perhaps the most significant factor that underlies the poor prognosis of PDAC. To date, combination chemotherapy remains the mainstay of trea...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117738/ https://www.ncbi.nlm.nih.gov/pubmed/34025067 http://dx.doi.org/10.3748/wjg.v27.i18.2105 |